HCR Update from Mark Sanna: In a case that could have broad ramifications for the pharmaceutical industry, a federal appeals court on Monday threw out the conviction of a sales representative who sold a drug for uses not approved by theFood and Drug Administration. The judges said that the ban on so-called off-label marketing violated the representative’s freedom of speech.